Maybe AstraZeneca couldn't spre a few bob to provide us some decent revenue :\ For me I can liken this annoucement to fairy floss, it's fluff (no real revenue) but pretty good fluff. Exactly like fairy floss.
We still need real commercialisation, real dollars. Going back to single digits IMO, in no time unless they can produce binding terms and $$ with an international mob.
Sentiment remains hold. Cap raise not yet required but not yet averted.
- Forums
- ASX - By Stock
- RAP
- Ann: AstraZeneca to use new ResApp software in clinical study
Ann: AstraZeneca to use new ResApp software in clinical study, page-43
-
- There are more pages in this discussion • 79 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online